Why Am I Not Losing Weight on Wegovy 1.7? Understanding Your Weight Loss Journey

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many patients experience a slowdown in weight loss after reaching the 1.7 mg semaglutide dose, even though they initially saw significant progress. This plateau is a normal metabolic adaptation—your body adjusts to the medication's effects over time, requiring strategic adjustments to continue moving forward.

How Semaglutide Works and Why Plateaus Develop

Semaglutide activates GLP-1 receptors in your brain and gut, reducing hunger signals and increasing feelings of fullness. Within the first 12 weeks, most patients experience rapid appetite suppression and weight loss. However, your body's chemistry adapts—receptor sensitivity gradually decreases, and your metabolism establishes a new baseline that resists further change.

This adaptation isn't a sign that semaglutide has stopped working. Instead, it reflects your body's homeostatic drive to maintain stability. Clinical research shows that continued weight loss requires either dose optimization, lifestyle intensification, or additional metabolic support beyond GLP-1 receptor activation alone.

Genetic Factors Behind Individual Weight Loss Resistance

Not everyone responds identically to semaglutide, and your genetics play a significant role. Variations in the GLP1R gene (rs6923761), FTO gene (rs9939609), and MC4R gene (rs17782313) influence how strongly you respond to appetite suppression and how your body burns calories. Some patients carry genetic predispositions that make them naturally resistant to single-pathway weight loss approaches.

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides related to weight regulation, identifying which biological systems drive your specific weight loss challenges. This insight allows for truly personalized treatment strategies rather than one-size-fits-all dosing. Patients with specific genetic profiles often benefit from combination therapies or dose adjustments tailored to their unique biology.

Practical Steps to Overcome a Semaglutide Weight Loss Plateau

If you've stalled on 1.7 mg semaglutide, your first move should be evaluating whether you've maximized behavioral factors: sleep quality, water intake, resistance training, and protein consumption directly impact how your body responds to GLP-1 therapy. Many patients see renewed progress by intensifying one of these areas before increasing medication dose.

For those who have optimized lifestyle factors, dose escalation remains an option. PlexusDx offers compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan with the flexibility to adjust your dose based on your body's response—your dose may need to go up, but your price won't. Additionally, exploring combination therapies like GLP-Squared (semaglutide plus tirzepatide) can activate multiple metabolic pathways simultaneously, overcoming single-drug resistance.

When to Consider Alternative or Combination Therapies

Tirzepatide, a newer compound that activates both GLP-1 and GIP receptors, addresses weight loss resistance through a dual-pathway mechanism. Patients who plateau on semaglutide alone often experience renewed progress with tirzepatide because it engages additional appetite-control circuits in your brain. Clinical trials show tirzepatide produces greater average weight loss than semaglutide at comparable timepoints.

PlexusDx's Precision Peptide Genetic Test identifies whether your genetics favor GLP-1-only therapy, GIP-pathway activation, or combination approaches. This personalized insight eliminates months of trial-and-error medication changes. PlexusDx compounded tirzepatide is $289 per month month-to-month, or from $249/mo on the 6-month plan, and GLP-Squared combination therapy (both compounds in one injection) is $289/mo month-to-month, or from $249/mo on the 3-month plan—same pricing tier, maximum biological impact.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is it normal to stop losing weight after 3-4 months on semaglutide?

Yes, weight loss plateaus are expected as your body adapts to the medication. This metabolic adjustment typically occurs between months 3-6 and doesn't mean the drug has failed. Most patients restart progress through dose optimization, behavioral refinement, or addition of complementary therapies.

Can I keep increasing my semaglutide dose indefinitely?

Semaglutide's approved maximum is 2.4 mg weekly, though compounded options allow medically supervised dosing. Beyond a certain threshold, further dose increases yield minimal additional weight loss while increasing side effect risk. This is why genetic testing and combination therapy strategies often prove more effective than chasing ever-higher doses.

How much does PlexusDx semaglutide cost compared to Wegovy?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), significantly lower than brand Wegovy ($935-$1,440 monthly at retail). PlexusDx serves all 50 states, requires no insurance, is HSA/FSA eligible, and maintains flat monthly pricing regardless of dose adjustments.

Are compounded semaglutide and tirzepatide as safe as brand-name versions?

PlexusDx partners exclusively with licensed 503A compounding pharmacies, which operate under rigorous FDA oversight and state pharmacy board regulations. Compounded medications undergo the same quality testing as brands. Your healthcare provider monitors your response just as they would with brand medications.

How does the Precision Peptide Genetic Test help break through a weight loss plateau?

The test identifies your genetic predispositions across 14 metabolic pathways, revealing whether your plateau stems from GLP-1 resistance, impaired GIP signaling, or dysregulation in other appetite-control peptides. This insight guides your clinician toward the specific medication or combination most likely to restart your progress, eliminating guesswork and accelerating results. The test is $298.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.